SAN FRANCISCO — Despite all the hopeful chatter about the life sciences industry making a rebound after a multiyear ...
In his annual letter, Flagship Pioneering’s Noubar Afeyan lays out a choice between near-term “human-made miracles” and a ...
2don MSNOpinion
Moderna chair says US assault on science is just beginning
Moderna Inc.’s chairman says the Trump administration’s vaccine policy changes are part of a broader attack on science that ...
In a new letter, Noubar Afeyan, Ph.D., co-founder of Moderna and CEO of Flagship Pioneering, warns that these actions risk undermining the foundations of science itself to the ultimate detriment of ...
The politicization of science is undermining the scientific method itself, the co-founder of the biotech firm Moderna warned.
Noubar Afeyan, one of biotech’s top investors, says U.S. policy is "taking a sledgehammer to our miracle machine." ...
Noubar Afeyan, founder and CEO of Flagship Pioneering, delivered some very relevant remarks, in my opinion, at this year’s MIT commencement. As over 3,000 students convened to matriculate, MIT ...
In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if... Moderna and Flagship Pioneering: Noubar Afeyan In ...
Flagship Pioneering is a hard business to describe, Noubar Afeyan admits. The Boston-based group he leads is not quite a pharma company, not just a research lab, and not exactly a VC firm. Instead, he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback